← Leaderboards
John J Sauk
University Of Maryland Baltimore
$3,003,437
Attributed
$3,003,437
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $352.7K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$3,003,437 · 2
By mechanism
R01$3,003,437 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Angela M. Brodie$7,232,468
- Stephen J Meltzer$26,520,343
- John T McDevitt$21,567,166
- Iris Lindberg$14,224,946
- Yibin Wang$17,505,902
Others in their field
Top investigators on “Cell Membrane”
- Dennis R. Burton · Scripps Research Institute$258,610,184
- Barton F Haynes · Duke University$123,162,119
- Ian A Wilson · Scripps Research Institute, The$73,499,092
- Robert M Stroud · University Of California, San Francisco$68,493,831
- Dennis L. Kasper · Harvard Medical School$58,511,900
- Rama Rao Amara · Emory University$54,637,697
Research focus
Cell MembraneSquamous Cell CarcinomaAthymic MouseYeast Two Hybrid SystemBinding ProteinsBiomarkerDoxorubicinHeat Shock ProteinsMonoclonal AntibodyNeoplasm /Cancer ChemotherapyNeoplasm /Cancer InvasivenessNeoplastic GrowthNonhuman Therapy EvaluationOral Pharyngeal NeoplasmPeptide LibraryPharmacokineticsProtein Protein InteractionSite Directed MutagenesisTissue /Cell CultureAntineoplasticsNeoplastic CellStress ProteinsProtease InhibitorCell Motility
Grant awards (11)
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$344,400
R01 · FY2006 · DE · contact PI
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$352,688
R01 · FY2005 · DE
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$352,688
R01 · FY2004 · DE
CELL SURFACE MARKER AND HOMING TARGET FOR ORAL SCC$275,519
R01 · FY2003 · DE
CELL SURFACE MARKER AND HOMING TARGET FOR ORAL SCC$352,316
R01 · FY2002 · DE
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$257,832
R01 · FY2002 · DE
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$253,690
R01 · FY2001 · DE
CELL SURFACE MARKER AND HOMING TARGET FOR ORAL SCC$252,450
R01 · FY2001 · DE
CELL SURFACE MARKER AND HOMING TARGET FOR ORAL SCC$58,410
R01 · FY2001 · DE
CELL SURFACE MARKER AND HOMING TARGET FOR ORAL SCC$252,450
R01 · FY2000 · DE
NOVEL SERPIN INHIBITOR OF ORAL SQUAMOUS CARCINOMA$250,994
R01 · FY2000 · DE